Angelo Gordon & Co., L.P. Illumina, Inc. Transaction History

Angelo Gordon & Co., L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$181.58 - $368.0 $1.82 Million - $3.68 Million	-10,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$303.87 - $423.8 $1.91 Million - $2.67 Million	-6,300 Reduced 38.65%	10,000 $3.49 Million
Q1 2021 May 17, 2021	BUY	$361.28 - $504.76 $5.89 Million - $8.23 Million	16,300 New	16,300 $6.26 Million
Q3 2018 Nov 14, 2018	SELL	$279.04 - $367.06 $21.9 Million - $28.8 Million	-78,400 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$228.17 - $292.07 $2.05 Million - $2.63 Million	9,000 Added 12.97%	78,400 $21.9 Million
Q1 2018 May 15, 2018	BUY	$209.54 - $253.91 $1.57 Million - $1.9 Million	7,500 Added 12.12%	69,400 $16.4 Million
Q3 2017 Nov 13, 2017	BUY	$172.3 - $213.93 $10.7 Million - $13.2 Million	61,900	61,900 $12.3 Million

913

139M

1.2M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $16.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Angelo Gordon & Co., L.P., based on Form 13F filings with the SEC.

Stay updated on Angelo Gordon & Co., L.P. with notifications on news.